Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "methodist hospital" | Open Studies | "Death" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
Condition: Delayed Graft Function
Interventions: Drug: QPI-1002;   Other: Placebo
2 Recruiting Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Condition: Advanced Cutaneous Squamous Cell Carcinoma
Intervention: Drug: REGN2810
3 Recruiting Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
Conditions: Advanced Cancer;   Advanced Malignancies
Interventions: Drug: REGN2810;   Radiation: Hypofractionated radiotherapy;   Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Carboplatin;   Drug: GM-CSF
4 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.